H. Lundbeck A/S: all 276 studies

Page 2 of 3. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.

• A Trial of Lu AG13909 in Adult Participants With Cushing's DiseaseActive, not recruitingNCT06471829Phase 2
• A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy MenCompletedNCT06337110Phase 1
• A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive TreatmentsCompletedNCT06323928Phase 2
• A Trial Investigating Lu AF28996 in Healthy Adult ParticipantsCompletedNCT06277609Phase 1
• A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian AdultsCompletedNCT06258720Phase 1
• A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult ParticipantsCompletedNCT06077786Phase 1
• A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)CompletedNCT06004180Phase 1
• A Study Investigating Lu AG06474 in Healthy Young ParticipantsTerminatedNCT05943327Phase 1
• Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic EncephalopathyCompletedNCT05626634Phase 2
• Observational Study in Multiple System AtrophyActive, not recruitingNCT05453058
• Study to Investigate LP352 in Subjects With Developmental and Epileptic EncephalopathiesCompletedNCT05364021Phase 1/2
• A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male ParticipantsCompletedNCT05320302Phase 1
• A Brain Imaging PET Study of [11C]-Lu AF90103 in Healthy Adult Male ParticipantsCompletedNCT05306366Phase 1
• A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chinese, and Japanese ParticipantsCompletedNCT05304910Phase 1
• Binding and Effects of Lu AG06466 in the Brain of Healthy MenCompletedNCT05219838Phase 1
• A Study Investigating Lu AG06466 in Healthy MenCompletedNCT05201092Phase 1
• Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian ParticipantsTerminatedNCT05177029Phase 1
• A Study Investigating Lu AG22515 in Healthy AdultsCompletedNCT05136053Phase 1
• A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass PollenCompletedNCT05126316Phase 1
• A Study of Lu AG06466 in Participants With Treatment Resistant Focal EpilepsyTerminatedNCT05081518Phase 1
• A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell LinesCompletedNCT05074459Phase 1
• Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in JapanCompletedNCT05064371Phase 3
• Safety, Tolerability and Pharmacokinetics of Eptinezumab in Healthy Chinese SubjectsCompletedNCT05045781Phase 1
• A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy ParticipantsCompletedNCT05028673Phase 1
• Safety and Tolerability of Lu AG06474 in Healthy Young MenCompletedNCT05003687Phase 1
• A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple SclerosisTerminatedNCT04990219Phase 1
• A Single Dose Study of Lu AG09222 in a Headache Model With Healthy SubjectsCompletedNCT04976309Phase 1
• A Study to Evaluate Lu AG06466 in Participants With FibromyalgiaTerminatedNCT04974359Phase 1
• A Study to Evaluate Lu AF90103 in Healthy MenTerminatedNCT04940949Phase 1
• Eptinezumab as Preventive Treatment of Migraine in Adults With MigraineCompletedNCT04921384Phase 3
• Eptinezumab in Adults With Migraine and Medication Overuse HeadacheCompletedNCT04772742Phase 3
• Drug Drug Interaction Study With Lu AG06466 in Young Healthy MenCompletedNCT04713254Phase 1
• Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)CompletedNCT04597450Phase 1
• A Study in Healthy Men to Investigate Uptake and Distribution of Lu AF88434 in the BrainCompletedNCT04538014Phase 1
• A Study in Children and Young People With Migraine to Learn What the Body Does to EptinezumabCompletedNCT04537429Phase 1
• Safety and Tolerability of Lu AG06479 in Healthy Young MenTerminatedNCT04473651Phase 1
• Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From DepressionCompletedNCT04448431Phase 4
• Binding of Lu AG06466 in the Brain in Healthy MenCompletedNCT04419636Phase 1
• Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and WomenCompletedNCT04405323Phase 1
• Eptinezumab in Healthy Japanese SubjectsCompletedNCT04336449Phase 1
• Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy SubjectsTerminatedNCT04322227Phase 1
• Vortioxetine in Patients With Depression and Early DementiaCompletedNCT04294654Phase 4
• Lu AF28996 in Participants With Parkinson's Disease (PD)CompletedNCT04291859Phase 1
• Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in IndiaCompletedNCT04288895Phase 4
• Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy SubjectsCompletedNCT04275115Phase 1
• Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)CompletedNCT04220996Phase 4
• Safety and Tolerability of Lu AF95245 in Healthy Young MenTerminatedNCT04199585Phase 1
• Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and WomanCompletedNCT04197349Phase 1
• Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD)TerminatedNCT04175132Phase 1
• Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's DiseaseCompletedNCT04149860Phase 1
• A Study Investigating Tablet Formulations of Lu AF11167 in Healthy SubjectsCompletedNCT04104503Phase 1
• Study Investigating the Safety and Tolerability of Lu AF88434 in Healthy Young MenCompletedNCT04082325Phase 1
• What the Body Does to Foliglurax in Healthy VolunteersCompletedNCT04002895Phase 1
• Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative SymptomsTerminatedNCT03929497Phase 2
• A Study Investigating Formulations of Vortioxetine Applied Under the Tongue in Healthy SubjectsCompletedNCT03884491Phase 1
• Study With Vortioxetine on Emotional Functioning in Patients With DepressionCompletedNCT03835715Phase 4
• A Positron Emission Tomography (PET) Study to Examine the Brain Binding Properties of a Novel Radioactive Compound [11C]-PXT012253 in Healthy SubjectsCompletedNCT03826134Early Phase 1
• Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to ADTerminatedNCT03819699Phase 1
• Study With Lu AF11167 for the Treatment of Negative Symptoms in Patients With SchizophreniaTerminatedNCT03793712Phase 2
• Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With DepressionCompletedNCT03766867Phase 2
• Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed ConditionsCompletedNCT03670095Phase 1
• Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed StateCompletedNCT03670082Phase 1
• A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)TerminatedNCT03668405Phase 1
• Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic DisorderCompletedNCT03625453Phase 2
• Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's DiseaseCompletedNCT03611569Phase 1
• Single Dose of Lu AF28996 to Healthy Young MenCompletedNCT03565094Phase 1
• Real-life Effectiveness of Vortioxetine in DepressionCompletedNCT03555136
• Single Ascending Dose Study of Lu AF76432 in Healthy Young MenCompletedNCT03531229Phase 1
• Bioequivalence Study to Compare Two Formulations of Deanxit®CompletedNCT03472651Phase 1
• Titration Study of ABX-1431CompletedNCT03447756Phase 1
• Bioequivalence Study of Lu AF35700CompletedNCT03394482Phase 1
• Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED)WithdrawnNCT03331848Phase 2
• Positron Emission Tomography (PET) Study in Patients With Alzheimer's DiseaseTerminatedNCT03307993Phase 1
• Pharmacokinetics of Lu AF35700 in Subjects With Renal ImpairmentTerminatedNCT03241147Phase 1
• Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing EnzymesCompletedNCT03195946Phase 1
• Study Investigating the Pharmacokinetic Properties of the Drug Lu AF35700 in Subjects With Liver Impairment and in Healthy SubjectsCompletedNCT03189615Phase 1
• Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's PatientsCompletedNCT03162874Phase 2
• Central Pain Study for ABX-1431CompletedNCT03138421Phase 1
• Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of AgeCompletedNCT03108625Phase 3
• Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and WomenCompletedNCT03103646Phase 1
• A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette SyndromeCompletedNCT03058562Phase 1
• An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural CorrelatesCompletedNCT02929264Phase 1
• Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive DisorderCompletedNCT02919501Phase 2
• Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective DisorderCompletedNCT02901587Phase 1
• Bioequivalence Study of Idalopirdine in Healthy SubjectsWithdrawnNCT02894515Phase 1
• A Study to Evaluate the Effects of ABX-1431 on Patients With Functional DyspepsiaTerminatedNCT02875678Phase 1
• Comparison of the Effectiveness of Brexpiprazole With That of RisperidoneWithdrawnNCT02758067Phase 3
• Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol FormulationsCompletedNCT02660840Phase 1
• A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female SubjectsCompletedNCT02639221Phase 1
• Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy MenCompletedNCT02436486Phase 1
• Investigating the Absorption, Metabolism and Excretion (AME) of IdalopirdineCompletedNCT02415907Phase 1
• Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's DiseaseTerminatedNCT02388152Phase 1
• Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and WomenCompletedNCT02386488Phase 1
• Bioequivalence Study of Idalopirdine Tablets 60 mgCompletedNCT02371707Phase 1
• Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney FunctionCompletedNCT02340195Phase 1
• Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking VortioxetineCompletedNCT02332954Phase 4
• Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive DisorderCompletedNCT02279966Phase 3
• Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive DisorderCompletedNCT02279953Phase 3
• Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive DisorderCompletedNCT02272517Phase 3
• Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167CompletedNCT02260830Phase 1

← H. Lundbeck A/S overview and focus areas